Drug
datopotamab deruxtecan
Marketed as DATROWAY.
Generic name
datopotamab deruxtecan
Brand names
DATROWAY
First FDA approval
2025-01-17
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761394 | DATROWAY | 2025-01-17 | DAIICHI SANKYO INC |
Manufacturers
DAIICHI SANKYO INC
Frequently asked questions
When was datopotamab deruxtecan FDA approved?
Earliest FDA approval on record: 2025-01-17.
What brand names are sold as datopotamab deruxtecan?
DATROWAY.
Sources
Appeal a datopotamab deruxtecan denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com